Status report on the use of tamoxifen to prevent breast cancer

被引：0

作者：

Nachtigall, LE ^{[1
]}

机构：

[1] NYU, Sch Med, Dept Obstet & Gynecol, New York, NY 10016 USA

来源：

MENOPAUSE: STATE OF THE ART - IN RESEARCH AND MANAGEMENT | 2003年

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：10 / 11

页数：2

共 10 条

[1] Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial [J].

Cauley, JA ;

Norton, L ;

Lippman, ME ;

Eckert, S ;

Krueger, KA ;

Purdie, DW ;

Farrerons, J ;

Karasik, A ;

Mellstrom, D ;

Ng, KW ;

Stepan, JJ ;

Powles, TJ ;

Morrow, M ;

Costa, A ;

Silfen, SL ;

Walls, EL ;

Schmitt, H ;

Muchmore, DB ;

Jordan, VC .

BREAST CANCER RESEARCH AND TREATMENT, 2001, 65 (02) :125-134

[2]

Clarke M, 1998, LANCET, V351, P1451

[3] Serum estradiol level and risk of breast cancer during treatment with raloxifene [J].

Cummings, SR ;

Duong, T ;

Kenyon, E ;

Cauley, JA ;

Whitehead, M ;

Krueger, KA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (02) :216-220

[4] Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].

Fisher, B ;

Costantino, JP ;

Wickerham, DL ;

Redmond, CK ;

Kavanah, M ;

Cronin, WM ;

Vogel, V ;

Robidoux, A ;

Dimitrov, N ;

Atkins, J ;

Daly, M ;

Wieand, S ;

Tan-Chiu, E ;

Ford, L ;

Wolmark, N .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388

[5] Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer [J].

Gail, MH ;

Costantino, JP ;

Bryant, J ;

Croyle, R ;

Freedman, L ;

Helzlsouer, K ;

Vogel, V .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (21) :1829-1846

[6] A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium [J].

Goldstein, SR ;

Scheele, WH ;

Rajagopalan, SK ;

Wilkie, JL ;

Walsh, BW ;

Parsons, AK .

OBSTETRICS AND GYNECOLOGY, 2000, 95 (01) :95-103

[7] UNUSUAL ULTRASONOGRAPHIC APPEARANCE OF THE UTERUS IN PATIENTS RECEIVING TAMOXIFEN [J].

GOLDSTEIN, SR .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 170 (02) :447-451

[8] Peptide antagonists of the human estrogen receptor [J].

Norris, JD ;

Paige, LA ;

Christensen, DJ ;

Chang, CY ;

Huacani, MR ;

Fan, DJ ;

Hamilton, PT ;

Fowlkes, DM ;

McDonnell, DP .

SCIENCE, 1999, 285 (5428) :744-746

[9] The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen [J].

Schwartz, LB ;

Snyder, J ;

Horan, C ;

Porges, RF ;

Nachtigall, LE ;

Goldstein, SR .

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1998, 11 (01) :48-53

[10] Association of tamoxifen and uterine sarcoma [J].

Wickerham, DL ;

Fisher, B ;

Wolmark, N ;

Bryant, J ;

Costantino, J ;

Bernstein, L ;

Runowicz, CD .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (11) :2758-2760

← 1 →